Anti-Nausea Drug Bendectin Linked to Increased Colorectal Cancer Risks: Study
A new study warns that Bendectin, an anti-nausea drug used in the 60s and 70s, may be contributing to increasing rates of colorectal cancer among certain age groups.
A new study warns that Bendectin, an anti-nausea drug used in the 60s and 70s, may be contributing to increasing rates of colorectal cancer among certain age groups.